Search Results - "Hau, Raymond K."

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Addressing the Clinical Importance of Equilibrative Nucleoside Transporters in Drug Discovery and Development by Hau, Raymond K., Wright, Stephen H., Cherrington, Nathan J.

    Published in Clinical pharmacology and therapeutics (01-10-2023)
    “…The US Food and Drug Administration (FDA), European Medicines Agency (EMA), and Pharmaceuticals and Medical Devices Agency (PMDA) guidances on small‐molecule…”
    Get full text
    Journal Article
  2. 2

    PF‐07321332 (Nirmatrelvir) does not interact with human ENT1 or ENT2: Implications for COVID‐19 patients by Hau, Raymond K., Wright, Stephen H., Cherrington, Nathan J.

    Published in Clinical and translational science (01-07-2022)
    “…The ongoing pandemic of severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2) and subsequently, coronavirus disease 2019 (COVID‐19), has led to the…”
    Get full text
    Journal Article
  3. 3

    Generation of a hTERT-Immortalized Human Sertoli Cell Model to Study Transporter Dynamics at the Blood-Testis Barrier by Hau, Raymond K, Miller, Siennah R, Wright, Stephen H, Cherrington, Nathan J

    Published in Pharmaceutics (22-10-2020)
    “…The blood-testis barrier (BTB) formed by adjacent Sertoli cells (SCs) limits the entry of many chemicals into seminiferous tubules. Differences in rodent and…”
    Get full text
    Journal Article
  4. 4

    Predicting disruptions to drug pharmacokinetics and the risk of adverse drug reactions in non-alcoholic steatohepatitis patients by Marie, Solène, Frost, Kayla L., Hau, Raymond K., Martinez-Guerrero, Lucy, Izu, Jailyn M., Myers, Cassandra M., Wright, Stephen H., Cherrington, Nathan J.

    Published in Acta pharmaceutica Sinica. B (01-01-2023)
    “…The liver plays a central role in the pharmacokinetics of drugs through drug metabolizing enzymes and transporters. Non-alcoholic steatohepatitis (NASH) causes…”
    Get full text
    Journal Article
  5. 5

    Testicular disposition of clofarabine in rats is dependent on equilibrative nucleoside transporters by Miller, Siennah R., Jilek, Joseph L., McGrath, Meghan E., Hau, Raymond K., Jennings, Erin Q., Galligan, James J., Wright, Stephen H., Cherrington, Nathan J.

    Published in Pharmacology research & perspectives (01-08-2021)
    “…Acute lymphoblastic leukemia (ALL) is the most common cancer in children and adolescents. Although the 5‐year survival rate is high, some patients respond…”
    Get full text
    Journal Article
  6. 6

    Drug Transporters at the Human Blood-Testis Barrier by Hau, Raymond K, Wright, Stephen H, Cherrington, Nathan J

    Published in Drug metabolism and disposition (01-05-2023)
    “…Transporters are involved in the movement of many physiologically important molecules across cell membranes and have a substantial impact on the…”
    Get full text
    Journal Article
  7. 7

    In Vitro and In Vivo Models for Drug Transport Across the Blood-Testis Barrier by Hau, Raymond K, Wright, Stephen H, Cherrington, Nathan J

    Published in Drug metabolism and disposition (01-09-2023)
    “…The blood-testis barrier (BTB) is a selectively permeable membrane barrier formed by adjacent Sertoli cells (SCs) in the seminiferous tubules of the testes…”
    Get full text
    Journal Article
  8. 8

    Localization of Xenobiotic Transporters Expressed at the Human Blood-Testis Barrier by Hau, Raymond K, Klein, Robert R, Wright, Stephen H, Cherrington, Nathan J

    Published in Drug metabolism and disposition (01-06-2022)
    “…The blood-testis barrier (BTB) is formed by basal tight junctions between adjacent Sertoli cells (SCs) of the seminiferous tubules and acts as a physical…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Physiological Characterization of the Transporter-Mediated Uptake of the Reversible Male Contraceptive H2-Gamendazole Across the Blood-Testis Barrier by Hau, Raymond K, Tash, Joseph S, Georg, Gunda I, Wright, Stephen H, Cherrington, Nathan J

    “…The blood-testis barrier (BTB) is formed by a tight network of Sertoli cells (SCs) to limit the movement of reproductive toxicants from the blood into the male…”
    Get full text
    Journal Article
  11. 11

    Nucleoside Reverse Transcriptase Inhibitor (NRTI) Interaction with Human Equilibrative Nucleoside Transporters 1 and 2 by Miller, Siennah R, Hau, Raymond K, Jilek, Joseph L, Morales, Mark N, Wright, Stephen H, Cherrington, Nathan J

    Published in Drug metabolism and disposition (01-07-2020)
    “…Equilibrative nucleoside transporters (ENTs) transport nucleosides across the blood-testis barrier (BTB). ENTs are of interest to study the disposition of…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Transporter Inhibition Profile for the Antivirals Tilorone, Quinacrine and Pyronaridine by Vignaux, Patricia A., Lane, Thomas R., Puhl, Ana C., Hau, Raymond K., Wright, Stephen H., Cherrington, Nathan J., Ekins, Sean

    Published in ACS omega (04-04-2023)
    “…Pyronaridine, tilorone and quinacrine are cationic molecules that have in vitro activity against Ebola, SARS-CoV-2 and other viruses. All three molecules have…”
    Get full text
    Journal Article
  14. 14
  15. 15